SUMMARY The mean pulmonary artery wedge pressure (PAWP), left atrial dimension (LAD) by echocardiography, and PTF-V, in the electrocardiogram were correlated with each other in 16 patients with acute myocardial infarction in the control period and after therapeutic intervention with either Dextran or furosemide and/or nitroprusside. No significant correlation was found between a normal control PAWP and the LAD. An increased control PAWP correlated well with an increased LAD (r = 0.98). No significant correlation was found between the LAD and the PAWP whether MORRIS AND ASSOCIATES found a positive correlation between abnormalities in the terminal portion of the P wave of the electrocardiogram in lead V1 and evidence of pressure or volume overload in patients with valvular heart disease.' Abnormalities in the terminal portion of the P wave in lead V, were also reported in separate studies in patients with pulmonary edema2 and in patients with acute myocardial infarction presenting with clinical and radiographic evidence of congestive heart failure.3 4 These electrocardiographic abnormalities tended to regress with clinical improvement, suggesting that an abnormal terminal negativity of the P wave in lead V, was the result of left atrial hypertension.3, 4 In a more recent study of patients with acute myocardial infarction, a direct correlation was found between the mean left atrial (LAm) pressure, as estimated by the pulmonary artery end-diastolic (PAEDP) or mean pulmonary artery wedge pressure (PAWP) and the P wave terminal force in V, (PTF-V,) in the standard 12-lead electrocardiogram.5 In this study, an abnormal PTF-V,, defined as greater than -0.03 mm-sec negativity, occurred in patients with initially elevated LAm pressure and regressed following reduction of the LAm pressure to normal.
PTF-V, in the electrocardiogram were correlated with each other in 16 patients with acute myocardial infarction in the control period and after therapeutic intervention with either Dextran or furosemide and/or nitroprusside. No significant correlation was found between a normal control PAWP and the LAD. An increased control PAWP correlated well with an increased LAD (r = 0.98). No significant correlation was found between the LAD and the PAWP whether MORRIS AND ASSOCIATES found a positive correlation between abnormalities in the terminal portion of the P wave of the electrocardiogram in lead V1 and evidence of pressure or volume overload in patients with valvular heart disease.' Abnormalities in the terminal portion of the P wave in lead V, were also reported in separate studies in patients with pulmonary edema2 and in patients with acute myocardial infarction presenting with clinical and radiographic evidence of congestive heart failure.3 4 These electrocardiographic abnormalities tended to regress with clinical improvement, suggesting that an abnormal terminal negativity of the P wave in lead V, was the result of left atrial hypertension. 3, 4 In a more recent study of patients with acute myocardial infarction, a direct correlation was found between the mean left atrial (LAm) pressure, as estimated by the pulmonary artery end-diastolic (PAEDP) or mean pulmonary artery wedge pressure (PAWP) and the P wave terminal force in V, (PTF-V,) in the standard 12-lead electrocardiogram.5 In this study, an abnormal PTF-V,, defined as greater than -0.03 mm-sec negativity, occurred in patients with initially elevated LAm pressure and regressed following reduction of the LAm pressure to normal.
In spite of these reports, it remains unclear whether the electrocardiogram is sufficiently sensitive to detect rapid fluctuations in left atrial pressure which may occur in the setting of an acute myocardial infarction and whether in patients with acute left atrial hypertension, left atrial dilatation plays a role in the genesis of the abnormalities in PTF-V,. A control 12-lead electrocardiogram was recorded at a paper speed of 25 mm/sec and a sensitivity of I mV/cm on a Hewlett-Packard model 15111B ECG machine. In addition, to facilitate P wave measurements, lead V1 was recorded at a paper speed of 50 mm/sec and a sensitivity of 2 mV/cm. P waves in V1 were measured by the method of Morris and associates' using a magnifying lens. The PTF-V1 was obtained from the product of the depth of the terminal deflection and its duration in lead V,. PTF-V, values were considered abnormal when the PTF-V, was -0.04 mm-sec or more negative.
Echocardiography was performed in all patients with an Ekoline-20 ultrasound unit and a Honeywell strip chart recorder. All echocardiograms were recorded with the patients in a slight left lateral decubitus position with 100 to 200 elevation of the head. The transducer was placed in the third, fourth, or fifth left sternal interspace. On recognition of the characteristic mitral valve echoes, the transducer was angled medially, posteriorly, and superiorly to obtain a recording of the aortic root and left atrium. Measurements of left atrial dimension were made directly posterior to the posterior aortic wall at ventricular end diastole between the external surface of the posterior aortic root and the internal surface of the left atrial wall. In our tracings, measurements of the left atrial dimension (LAD) at end diastole were more accurately defined than at end systole. The range of normal for LAD at end diastole is from 7 to 30 mm.6
After the control measurements, the 11 patients with a PAWP of 10 mm Hg or less received a low molecular weight dextran (Dextran 40) intravenous infusion over a 10 min period until the PAWP was increased to at least twice the control value or until 500 cc had been infused. The PAWP was monitored at frequent intervals during the infusion, and was not allowed to exceed 20 mm Hg. The five subjects whose control PAWP exceeded 15 mm Hg were treated with intravenous furosemide and/or nitroprusside to reduce the PAWP to below 15 mm Hg.
Upon reaching the desired PAWP changes, the PAWP was recorded and a 12-lead ECG and an echocardiogram were then obtained in rapid sequence as described for the Table I indicates the individual values and the means ± 1 SD in the control period and after Dextran infusion for the PAWP, the LAD by echocardiography, and the PTF-V, in each of the 11 patients with acute myocardial infarction and a normal control PAWP. Table 2 indicates the individual values and the means ± 1 SD in the control period and after intravenous furosemide and/or nitroprusside for the PAWP, the LAD by echocardiography, and the PTF-V, in each of the five patients with acute myocardial infarction and an elevated control PAWP. Table 3 indicates the mean values ± I SD in the control period for the PAWP, the LAD by echocardiography, and the PTF-V, in the entire group of 16 patients with acute myocardial infarction.
For the entire group of 16 patients, the association between the control PAWP and the control LAD was r = 0.63; the association between the control PAWP and the control PTF-V, was r = 0.24; the association between the control PTF-V1 and the control LAD was r = 0.21.
For the 11 patients with a normal control PAWP, the association between the control PAWP and the control LAD was r = 0.33; the association between the control PAWP and the control PTF-V, was r = 0.40; the association between the control PTF-V, and the control LAD was r = 0.39.
For the five patients with an elevated control PAWP, the correlation between the control PAWP and the control LAD was r = 0.98; the association between the control PAWP well with an elevated control PAWP. However, the LAD cannot be used to quantitate the PAWP before intervention, and cannot be used to assess the PAWP after intervention.
